Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/3016% below fair value

$1.40−0.10 (-6.67%)

Close on Nov 12, 2026Market cap $11.73MP/E –Yield –

Femasys EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Femasys has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is FEMY.

Revenue growth21.9% · median 36.5%

Gross margin60.9% · median 50.9%

Operating margin-763.9% · median -287.8%

Net margin-511.8% · median -269.3%

Advertisement
300 × 250

See a number that looks wrong?